Empire Financial Management Company, LLC
Position in ABT — Abbott Laboratories
CIK 1971875
NEW YORK, NY
Position in ABT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,507,612
-$1,091,468 QoQ
Shares Held
24,424
-15.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Empire Financial Management Company, LLC holds $9,488,957 across 5 Medical Devices names. ABT ranks #3 (26.4% of the industry book) .
All Filings in ABT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,507,612 | 24,424 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,599,080 | 28,726 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,377,824 | 40,151 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,409,117 | 39,770 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,258,776 | 39,644 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,448,163 | 39,326 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,422,789 | 38,793 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $3,999,599 | 38,491 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $4,120,580 | 37,436 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $3,590,326 | 37,071 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,044,751 | 37,101 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,081,790 | 40,310 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||